Oxomemazine
Spezifikationen
3689-50-7CAS-Nummer
222-996-8EG-Nummer
3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amineIUPAC-Name
C18H22N2O2SChemische Formel
330.4 g/molMolekulargewicht
Oxomemazine; 3689-50-7; Dysedon; Doxergan; Imakol; Oxomemazina; Oxomemazinum; Oplex; Exe-top; Trimeprazine 5,5-dioxide; RP 6847; RP-6847; 305MB38V1C; 6487-RP; 6847-RP; DTXSID5023405; PHENOTHIAZINE, 10-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-, 5,5-DIOXIDE; Phenothiazine, 10-[3-(dimethylamino)-2-methylpropyl]-, 5,5-dioxide; (+-)-Oxomemazine; RefChem:857801; DTXCID103405; R06AD08; 10-(3-(dimethylamino)-2-methylpropyl)-10H-5lambda6-phenothiazine-5,5-dione; 222-996-8; Dosegran; Oxymemazine; 10-(3-(diMethylaMino)-2-Methylpropyl)-10H-phenothiazine 5,5-dioxide; Alimemazine S,S-dioxide; (+)-Oxomemazine; (-)-Oxomemazine; MFCD00868197; 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; Oxomemazine, (+)-; Oxomemazine, (-)-; 10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine 5,5-dioxide; 10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine-5,5-dioxide; Q824SGH3RN; (+/-)-OXOMEMAZINE; 6847 R.P.; 5GP9538P4S; 10H-Phenothiazine-10-propanamine, N,N,.beta.-trimethyl-, 5,5-dioxide; Oxomemazine (INN); OXOMEMAZINE [INN]; 174508-14-6; Oxomemazin; Trimeprazine Sulphone; Oxomemazine; Oxomemazine [INN:DCF]; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide; Oxomemazinum [INN-Latin]; Oxomemazina [INN-Spanish]; EINECS 222-996-8; 174508-13-5; NCGC00182075-03; BRN 0289178; UNII-305MB38V1C; 10-[3-(Dimethylamino)-2-methylpropyl]-10H-phenothiazine 5,5-Dioxide; Doxergan (TN); OXOMEMAZINE [MI]; Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine [French]; UNII-Q824SGH3RN; OXOMEMAZINE [MART.]; OXOMEMAZINE [WHO-DD]; 4-27-00-01270 (Beilstein Handbook Reference); MLS006009989; SCHEMBL423634; UNII-5GP9538P4S; orb1298159; CHEMBL2104734; SCHEMBL29378205; CHEBI:135408; ARD14338; Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine; Oxomemazine 1.0 mg/ml in Methanol; AKOS015962134; 6487 RP; 6847 RP; DB13820; NCGC00182075-02; AC-15943; DA-76517; MS-24971; SMR004701064; SY244359; HY-136587; CS-0131898; NS00002586; T9353; D07401; F20164; F816758; SR-01000883964; Q3359071; SR-01000883964-1; 10H-Phenothiazine-10-propanamine, N,N,|A-trimethyl-, 5,5-dioxide; 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide, (+)-; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide, (-)-; 3-(5,5-Dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethyl-1-propanamine #; 3-(5,5-dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; 10-[3-(Dimethylamino)-2-methylpropyl]-5lambda~6~-phenothiazine-5,5(10H)-dione; 10H-PHENOTHIAZINE-10-PROPANAMINE, N,N,.BETA.-TRIMETHYL-, 5,5-DIOXIDE, (+)-; 10H-PHENOTHIAZINE-10-PROPANAMINE, N,N,.BETA.-TRIMETHYL-, 5,5-DIOXIDE, (-)-Synonyme
Produkte, die Oxomemazine enthalten
TOPLEXIL 0,33 mg/ml, siropTOPLEXIL 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE ZENTIVA 0,33 mg/ml, siropOXOMEMAZINE ZENTIVA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE VIATRIS 0,33 mg/mL, siropOXOMEMAZINE VIATRIS 0,33 mg/mL SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE UPSA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE TEVA 0,33 mg/ml, siropOXOMEMAZINE TEVA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE SANDOZ CONSEIL 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE SANDOZ 0,33 mg/ml, siropOXOMEMAZINE SANDOZ 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassique
Seite 1 von 3
Unternehmen, die Oxomemazine verkaufen
CT
Công ty Cổ phần Dược Trung ương MediplantexViet NamCT
Công Ty Cổ Phần Dược Phẩm Tv.Pharm Viet Nam
CT
Công Ty TNHH Wooshin Đồng Nai Viet Nam
CT
Công ty cổ phần dược phẩm Gia NguyễnViet Nam
Seite 1 von 2